287 related articles for article (PubMed ID: 32979387)
1. Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trial.
Clyman RI; Kaempf J; Liebowitz M; Erdeve O; Bulbul A; Håkansson S; Lindqvist J; Farooqi A; Katheria A; Sauberan J; Singh J; Nelson K; Wickremasinghe A; Dong L; Hassinger DC; Aucott SW; Hayashi M; Heuchan AM; Carey WA; Derrick M; Fernandez E; Sankar M; Leone T; Perez J; Serize A;
J Pediatr; 2021 Feb; 229():283-288.e2. PubMed ID: 32979387
[TBL] [Abstract][Full Text] [Related]
2. The effect of prolonged tracheal intubation on the association between patent ductus arteriosus and bronchopulmonary dysplasia (grades 2 and 3).
Clyman RI; Hills NK
J Perinatol; 2020 Sep; 40(9):1358-1365. PubMed ID: 32669644
[TBL] [Abstract][Full Text] [Related]
3. Patent ductus arteriosus, tracheal ventilation, and the risk of bronchopulmonary dysplasia.
Clyman RI; Hills NK; Cambonie G; Debillon T; Ligi I; Gascoin G; Patkai J; Beuchee A; Favrais G; Durrmeyer X; Flamant C; Rozé JC
Pediatr Res; 2022 Feb; 91(3):652-658. PubMed ID: 33790415
[TBL] [Abstract][Full Text] [Related]
4. Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension.
Nawaytou H; Hills NK; Clyman RI
Pediatr Res; 2023 Aug; 94(2):547-554. PubMed ID: 36804505
[TBL] [Abstract][Full Text] [Related]
5. Association between Hemodynamically Significant Patent Ductus Arteriosus and Bronchopulmonary Dysplasia.
Schena F; Francescato G; Cappelleri A; Picciolli I; Mayer A; Mosca F; Fumagalli M
J Pediatr; 2015 Jun; 166(6):1488-92. PubMed ID: 25882876
[TBL] [Abstract][Full Text] [Related]
6. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.
Deng Y; Zhang H; Zhao Z; Du J; Bai R; McNamara PJ
Eur J Pediatr; 2022 Aug; 181(8):3131-3140. PubMed ID: 35838780
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia.
Willis KA; Weems MF
Congenit Heart Dis; 2019 Jan; 14(1):27-32. PubMed ID: 30343505
[TBL] [Abstract][Full Text] [Related]
8. Risk factors that affect the degree of bronchopulmonary dysplasia in very preterm infants: a 5-year retrospective study.
Yang T; Shen Q; Wang S; Dong T; Liang L; Xu F; He Y; Li C; Luo F; Liang J; Tang C; Yang J
BMC Pediatr; 2022 Apr; 22(1):200. PubMed ID: 35413820
[TBL] [Abstract][Full Text] [Related]
9. [Bronchopulmonary dysplasia in the newborn infant. Occurrence of bronchopulmonary dysplasia in the severe neonatal respiratory syndrome complicated by patent ductus arteriosus treated with mechanical ventilation, in newborn infants of gestational age under 36 weeks].
Silvestri G; Tuo P; Soliani M; Moretti R; Nahum L; Ivani G
Minerva Pediatr; 1984 Feb; 36(4):163-8. PubMed ID: 6738469
[No Abstract] [Full Text] [Related]
10. Patent Ductus Arteriosus and the Effects of Its Late Closure in Preterm Infants with Severe Bronchopulmonary Dysplasia.
Ansems SM; Kirpalani H; Mercer-Rosa L; Wang Y; Hopper RK; Fraga MV; Jensen EA
Neonatology; 2019; 116(3):236-243. PubMed ID: 31269508
[TBL] [Abstract][Full Text] [Related]
11. Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.
Gentle SJ; Travers CP; Clark M; Carlo WA; Ambalavanan N
Am J Respir Crit Care Med; 2023 Apr; 207(7):921-928. PubMed ID: 36378949
[No Abstract] [Full Text] [Related]
12. Relationship between Duration of Infant Exposure to a Moderate-to-Large Patent Ductus Arteriosus Shunt and the Risk of Developing Bronchopulmonary Dysplasia or Death Before 36 Weeks.
Clyman RI; Hills NK; Liebowitz M; Johng S
Am J Perinatol; 2020 Jan; 37(2):216-223. PubMed ID: 31600791
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.
Slaughter JL; Reagan PB; Newman TB; Klebanoff MA
JAMA Pediatr; 2017 Mar; 171(3):e164354. PubMed ID: 28046188
[TBL] [Abstract][Full Text] [Related]
14. Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Villamor E; van Westering-Kroon E; Gonzalez-Luis GE; Bartoš F; Abman SH; Huizing MJ
JAMA Netw Open; 2023 Nov; 6(11):e2345299. PubMed ID: 38015504
[TBL] [Abstract][Full Text] [Related]
15. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
Potsiurko S; Dobryanskyy D; Sekretar L
BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
[TBL] [Abstract][Full Text] [Related]
16. Patent ductus arteriosus, its treatments, and the risks of pulmonary morbidity.
Clyman RI
Semin Perinatol; 2018 Jun; 42(4):235-242. PubMed ID: 29958703
[TBL] [Abstract][Full Text] [Related]
17. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants.
Mirza H; Garcia J; McKinley G; Hubbard L; Sensing W; Schneider J; Oh W; Wadhawan R
J Perinatol; 2019 Dec; 39(12):1648-1655. PubMed ID: 31554913
[TBL] [Abstract][Full Text] [Related]
18. The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia.
Clyman RI
Semin Perinatol; 2013 Apr; 37(2):102-7. PubMed ID: 23582964
[TBL] [Abstract][Full Text] [Related]
19. Changes in Patent Ductus Arteriosus Treatment Strategy and Respiratory Outcomes in Premature Infants.
Relangi D; Somashekar S; Jain D; Vanbuskirk S; Bancalari E; Sosenko I; Claure N
J Pediatr; 2021 Aug; 235():58-62. PubMed ID: 33894266
[TBL] [Abstract][Full Text] [Related]
20. Patent ductus arteriosus (PDA) and pulmonary morbidity: can early targeted pharmacologic PDA treatment decrease the risk of bronchopulmonary dysplasia?
Clyman RI; Hills NK
Semin Perinatol; 2023 Mar; 47(2):151718. PubMed ID: 36882361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
